T1	Participants 81 147	severe neurological manifestations in systemic lupus erythematosus
T2	Participants 415 679	two tertiary care centres of patients with SLE according to the ACR criteria, with incident (no more than 15 days) onset of severe NP manifestations such as seizures, optic neuritis, peripheral or cranial neuropathy, coma, brainstem disease, or transverse myelitis
T3	Participants 1124 1143	32 patients studied
T4	Participants 1289 1308	acute, severe NPSLE
T5	Participants 161 232	Severe neurological involvement in systemic lupus erythematosus (NPSLE)
